Impact and Cost-Effectiveness of Rotavirus Vaccination in Bangladesh
This article, published in Vaccine, evaluates the impact and cost-effectiveness of a routine infant rotavirus vaccination program in Bangladesh, a country that has applied for Gavi, the Vaccine Alliance support with a plan to introduce rotavirus vaccination in 2018. The authors used the Pan American Health Organization's TRIVAC model to assess introduction of two-dose rotavirus vaccination in the country across three mortality scenarios—low, high, and midpoint. Results indicate that, over ten years, rotavirus vaccination would prevent 4,000 deaths, nearly 500,000 hospitalizations, and 3 million outpatient visits in the base scenario. Based on these findings, the authors conclude that a routine rotavirus vaccination program is highly likely to be cost-effective in Bangladesh, and that other countries in the region may also find rotavirus vaccination to be both cost-effective and affordable.
Author: Pecenka C, Parashar U, Tate JE, et al.
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Pecenka C, Parashar U, Tate JE, et al. Impact and Cost-Effectiveness of Rotavirus Vaccination in Bangladesh. Vaccine. 2017;35(32):3982-3987.
Resource types: Peer-reviewed journal